Evolent Health, Inc. 4
4 · Evolent Health, Inc. · Filed May 23, 2017
Insider Transaction Report
Form 4
McGrane Nicholas
Chief Financial Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2017-05-19$3.84/sh+47,508$182,431→ 79,592 total - Sale
Class A Common Stock
2017-05-19$24.30/sh−47,508$1,154,444→ 32,084 total - Exercise/Conversion
Class A Common Stock Option (right to buy)
2017-05-19−47,508→ 222,952 totalExercise: $3.84Exp: 2024-04-01→ Class A Common Stock (47,508 underlying)
Footnotes (2)
- [F1]Includes restricted stock units under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission.
- [F2]The Class A Common Stock Options exercised vested on November 1, 2015.